Elevance Health, Inc. (ELV) operating KPIs
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)
Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –
Elevance Health carelonRx — Quarterly Adjusted Prescription Scripts (M)
Retail and mail-order prescription volume with 90-day fills counted as 3 adjusted scripts (Q4 figure shown in 10-K annual column).
Latest, Q3 2026
82.6
Period ended Sep 30, 2026
Change on a year earlier
-2.8%
85 in Q3 2025
History
20 quarters
Since Q4 2021
Sources
16
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | CarelonRx — Quarterly Adjusted Prescription Scripts (M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 82.6 | -2.8% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2026 | Jun 30, 2026 | 80.9 | -2.9% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q1 2026 | Mar 31, 2026 | 80.3 | -4.3% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q4 2025 | Dec 31, 2025 | 88.5 | +6.8% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q3 2025 | Sep 30, 2025 | 85 | +6.0% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2025 | Jun 30, 2025 | 83.3 | +6.5% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2025 | Mar 31, 2025 | 83.9 | +9.0% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2024 | Dec 31, 2024 | 82.9 | +6.3% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2024 | Sep 30, 2024 | 80.2 | +3.8% | 8-K ER (FY2025Q3, 2025-10-21) ↗ |
| Q2 2024 | Jun 30, 2024 | 78.2 | +1.0% | 8-K ER (FY2025Q2, 2025-07-17) ↗ |
| Q1 2024 | Mar 31, 2024 | 77 | +1.7% | 8-K ER (FY2025Q1, 2025-04-22) ↗ |
| Q4 2023 | Dec 31, 2023 | 78 | -4.9% | 8-K ER (FY2024Q4, 2025-01-23) ↗ |
| Q3 2023 | Sep 30, 2023 | 77.3 | +0.5% | 8-K ER (FY2024Q3, 2024-10-17) ↗ |
| Q2 2023 | Jun 30, 2023 | 77.4 | +1.3% | 8-K ER (FY2024Q2, 2024-07-17) ↗ |
| Q1 2023 | Mar 31, 2023 | 75.7 | +3.7% | 8-K ER (FY2024Q1, 2024-04-18) ↗ |
| Q4 2022 | Dec 31, 2022 | 82 | -2,150.0% | 8-K ER (FY2023Q4, 2024-01-24) ↗ |
| Q3 2022 | Sep 30, 2022 | 76.9 | – | 8-K ER (FY2023Q3, 2023-10-18) ↗ |
| Q2 2022 | Jun 30, 2022 | 76.4 | – | 8-K ER (FY2023Q2, 2023-07-19) ↗ |
| Q1 2022 | Mar 31, 2022 | 73 | – | 8-K ER (FY2023Q1, 2023-04-19) ↗ |
| Q4 2021 | Dec 31, 2021 | -4 | – | 10-K (FY2023, 2024-02-21) ↗ |
Cite this data
StockData. (2026). Elevance Health CarelonRx — Quarterly Adjusted Prescription Scripts (M), quarterly Q4 2021–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/carelonrx_adjusted_scripts
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.